Page 2 - Stem Cell Transplant Program News Today

The GVHD experts discuss recent advancements in chronic GVHD treatment, focusing on agents ruxolitinib, ibrutinib, and belumosudil and their mechanisms of action. The panel emphasizes the need for ongoing research and clinical trials to refine treatment strategies.

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss the complexities of chronic GVHD management, highlighting recent developments and efforts to reduce reliance on steroids.

The panel reviews recent developments in treatments, therapeutic approaches post-transplant, and the importance of clear communication in navigating patient expectations.

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss challenges in detecting and diagnosing chronic GVHD. The panel advocates for vigilant communication, early detection, and ongoing patient education for comprehensive post-transplant care.

The expert panel explores the immunological aspects of chronic GVHD, highlighting challenges in simultaneous management, addressing fibrosis, and emphasizing the importance of early intervention in evolving transplant care practices.

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.

The Windsor Cancer Centre Foundation has announced that $387,462 has been raised by the 2023 ‘Grow On’ campaign, with money still coming in.

More than $347,000 has been raised to support the launch of a stem cell transplant program in Windsor.

Grow On Windsor’s fundraising efforts have raised $387,462 to date with donations still rolling in. Funds raised go to support the launch of a Stem Cell

This November, the Windsor Cancer Centre Foundation’s Grow On Windsor campaign returns, with funds raised going to support the launch of a Stem Cell